Some of the effective factors in the pathogenesis of gastro-oesophageal reflux disease
- PMID: 30320456
- PMCID: PMC6237569
- DOI: 10.1111/jcmm.13939
Some of the effective factors in the pathogenesis of gastro-oesophageal reflux disease
Abstract
Oesophageal adenocarcinoma is one of the most fatal tumours to affect the digestive tract and is the eighth most common malignancy worldwide. Gastro-oesophageal reflux has an important role in the incidence of adenocarcinoma of the oesophagus. Gastro-oesophageal reflux disease (GERD) is a multifactorial, acid-peptic disorder that results from the reflux of noxious material from the stomach into the oesophagus. The refluxed material causes the occurrence of oesophageal inflammation which creates a condition that is called reflux oesophagitis. The prevalence of this disease has increased dramatically in recent decades, mostly in the western world, where it affects about 10% to 30% of the population. The aetiology of oesophageal mucosal damage is complicated. Many inflammatory mediators are produced within the gastrointestinal (GI) tract, but their contributions in pathophysiology and disease pathogenesis have not been well investigated. Despite the protective barrier provided by the oesophageal mucosa, refluxed materials can cause oxidative injury and in?ammatory responses that involve the epithelium and immune cells. The analysing cellular events in gastro- oesophageal reflux disease and physiological responses to such conditions are important and necessary for a better grasp of the pathogenesis of GERD and the expansion of new treatments. Therefore, we want to discuss some of the important and key factors of GERD disease in this article.
Keywords: COX; GERD; HIF; MPO; cytokines; inflammatory factors; oesophagitis.
© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Figures
Similar articles
-
Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats.Gut. 2013 Jan;62(1):6-14. doi: 10.1136/gutjnl-2011-301389. Epub 2012 Jan 27. Gut. 2013. PMID: 22287598
-
Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease.Aliment Pharmacol Ther. 2006 Sep;24 Suppl 2:17-26. doi: 10.1111/j.1365-2036.2006.03037.x. Aliment Pharmacol Ther. 2006. PMID: 16939429 Review.
-
[Ethiopathogenesis of gastroesophageal reflux disease].Cas Lek Cesk. 2000 Aug 2;139(15):455-9. Cas Lek Cesk. 2000. PMID: 22666924 Review. Czech.
-
Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?Gut. 2005 Mar;54 Suppl 1(Suppl 1):i21-6. doi: 10.1136/gut.2004.041558. Gut. 2005. PMID: 15711004 Free PMC article. Review.
-
[Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].Pol Merkur Lekarski. 2009 May;26(155):385-9. Pol Merkur Lekarski. 2009. PMID: 19606680 Polish.
Cited by
-
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned.Diagnostics (Basel). 2023 Aug 12;13(16):2664. doi: 10.3390/diagnostics13162664. Diagnostics (Basel). 2023. PMID: 37627923 Free PMC article. Review.
-
Association of anthropometric indicators with oesophageal squamous carcinoma and precancerous lesions in people aged 40-69 years from high-risk setting in China: a population-based study.BMJ Open. 2025 Jul 28;15(7):e087639. doi: 10.1136/bmjopen-2024-087639. BMJ Open. 2025. PMID: 40730401 Free PMC article.
-
A Study on Risk Factors Associated with Reflux Esophagitis in Patients Undergoing Esophageal Cancer Surgery.J Healthc Eng. 2022 Mar 27;2022:3409693. doi: 10.1155/2022/3409693. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jan 25;2023:9843745. doi: 10.1155/2023/9843745. PMID: 35388335 Free PMC article. Retracted.
-
Causal relationship between air pollution, lung function, gastroesophageal reflux disease, and non-alcoholic fatty liver disease: univariate and multivariate Mendelian randomization study.Front Public Health. 2024 Apr 29;12:1368483. doi: 10.3389/fpubh.2024.1368483. eCollection 2024. Front Public Health. 2024. PMID: 38746002 Free PMC article.
-
Multidimensional mechanisms and therapies underlying gastroesophageal reflux disease: focus on immunity, signaling pathways, and the microbiota-gut-brain axis.Front Immunol. 2025 Jul 18;16:1629944. doi: 10.3389/fimmu.2025.1629944. eCollection 2025. Front Immunol. 2025. PMID: 40755761 Free PMC article. Review.
References
-
- Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41(2):131‐137. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous